Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-11-30 Major Shareholding Noti…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document text is very short (491 characters) and announces a change in shareholding percentage by a major shareholder (Baillie Gifford & Co) in Novozymes, specifically stating the new holding is below a reporting threshold (reduced to 4.92% from 5.10%). This directly corresponds to the definition of 'Major Shareholding Notification' (MRQ), which covers changes in significant share ownership levels crossing thresholds, as mandated by securities laws (Værdipapirhandelslovens paragraf 29). It is not an earnings release, a full report, or a management change.
2016-11-30 Danish
Storaktionærmeddelelse
Major Shareholding Notification Classification · 100% confidence The document is a 'Storaktionærmeddelelse' (Major Shareholder Announcement) from Novozymes. It explicitly states that Baillie Gifford & Co has reduced its shareholding in the company from 5.10% to 4.92%. This falls directly under the definition of a Major Shareholding Notification (MRQ), which tracks changes in significant ownership levels.
2016-11-30 English
Storaktionærmeddelelse
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholding levels by Baillie Gifford & Co in Novozymes A/S. It explicitly mentions the percentage of shares held (4.92%) and references the Danish Securities Trading Act, which is standard for major shareholding notifications. This fits the definition of a Major Shareholding Notification (MRQ).
2016-11-30 English
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text is very short (406 characters) and announces the completion of a share buyback program ('tilbagekøb af B-aktier') up to a specified value (2 mia. kr.). It provides specific details on the number of shares bought and the total transaction value. This directly relates to the company transacting in its own shares. The final line, 'Læs hele meddelelsen i PDF format' (Read the full announcement in PDF format), suggests this is a brief announcement rather than the full regulatory filing itself. Therefore, the most specific category is Transaction in Own Shares (POS).
2016-11-16 Danish
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document explicitly states that Novozymes has 'completed the announced share buyback program of B shares worth up to DKK 2 billion'. It details the number of shares purchased and the total transaction value under the stock buyback program. This directly relates to the company transacting in its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS). The document is very short and mentions reading the full announcement in PDF, but the core content is the completion of the buyback, making POS more specific than RPA or RNS.
2016-11-16 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement (No. 57) detailing the completion of a share buyback program. It provides specific transaction data, including the number of shares purchased, average prices, and transaction values, as well as an appendix with detailed trading logs. This falls under the category of a company reporting on its own share repurchase activities.
2016-11-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.